Treatment of Hyperlipidemia with Ayurvedic medicine ARTHRAKSHA GHANVATI

CLINICAL STUDY IN THE MANAGEMENT OF MEDOROGA WITH SPECIAL REFERENCE TO DYSLIPIDEMIA WITH ARTHRAKSHA GHANVATI

Status

Recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2017/07/009133

Enrollment

Registered

2017-07-27

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Dyslipidemia

Interventions

Intervention1: Arthraksha Ghanvati: Contents:Haritaki,Vacha,Rasna,Pippali,Nagar,Shati,Pushkarmool Dose:2 tab (500mg each) twice a day before meal,Total Duration:8 weeks, Anupana:Koshanjala Control In

Eligibility

Inclusion criteria

Inclusion criteria: Patients having mild to moderated elevation of LDL,Total cholesterol, and Triglycerides, and HDL less than40mg/dl.

Exclusion criteria

Exclusion criteria: Patients who have received anti cholesterol medication within last 8 weeks. Uncontrolled and metabolic disorder other than Dyslipidemia.

Design outcomes

Secondary

Measure	Time frame
1. Lipid profile values (pre and post treatment) 2. Body Mass Index Timepoint: 12 weeks	—

Primary

Measure	Time frame
Symptoms of Medoroga will be improved after the treatment.Timepoint: 12 weeks	—

Countries

India

Contacts

Public ContactDr NJ Trivedi

Parul Institute of Ayurved

nj.trivedi30@gmail.com9824846993

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026